Qsar and Docking Studies of New Triazolopiperazine Derivatives as Potent Hypoglycemic Candidates
Qsar and Docking Studies of New Triazolopiperazine Derivatives as Potent Hypoglycemic Candidates

Swarna Bharathi Kalli; Velmurugan Vadivel

Volume 6, Issue 7 , July 2023, , Pages 1598-1613

https://doi.org/10.26655/JMCHEMSCI.2023.7.11

Abstract
  Dipeptidyl peptidase 4 (DPP-4) inhibition is a promising therapy for type 2 diabetes. Inhibition of DPP-4 limits the breakdown of glucagon-like peptide 1 (GLP-1), hence increasing functional ...  Read More